Mostrando 10 resultados de: 11
Filtros aplicados
Association of PPARγ2 GENE Pro12Ala allelic variant with obesity and metabolic syndrome components in a population of Maracaibo
ArticleAbstract: Introduction: In this study the association of rs1801282 allelic variant, g. 68777C G (Pro12Ala) ofPalabras claves:Metabolic syndrome, obesity, PPARγ2, Pro12Ala, Rs1801282Autores:Arráiz N., Carem Prieto, Marcucci R., Marín E., Mújica A., Mujica E., Perez D., Ramos M., Rojas-Quintero J., Sánchez M.P., Urdaneta B., Valmore BermúdezFuentes:scopusBiologic Behavior and optimal cut-off point estimation for Serum Fasting Insulin: A report from the Maracaibo City Metabolic Syndrome Prevalence Study
ArticleAbstract: Introduction: Insulin resistance is a metabolic state in which tissue effects of insulin are diminisPalabras claves:Cut-off point, hyperinsulinemia, Insulin, Insulin Resistance, Metabolic syndromeAutores:Amell A., Arráiz N., Calvo M.J., Carem Prieto, Chávez C., Chávez-Castillo M., David A., Escalona C., Gómez M.C., Lubo A., Martínez M.S., Mengual-Moreno E., Rojas-Quintero J., Romero J., Salazar-Vílchez J., Toledo A., Valero P., Valmore Bermúdez, Velasco M.Fuentes:googlescopusAbnormally high lipoprotein(a) levels in African-American communities from venezuela faced to other african-descending populations: Are ethnic origins related?
ArticleAbstract: Objective. Lipoprotein(a) is an independent risk factor for coronary artery disease. In Venezuela, LPalabras claves:Apo(a), Cardiovascular disease, Lipoprotein (a), risk factorAutores:Amell A., Aparicio D., Arráiz N., Cano-Ponce C., Ciszek A., Faria J., Gotera D., Guerra-Torres X.E., Medina M.T., Mengual-Moreno E., Nuñez M., Reyna-Villasmil N., Rojas E.R., Seyfi H.A., Sorell L.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopusAllelic variant UCP3-55CT gene in obese individuals with and without anthropometric and metabolic alterations in Maracaibo municipality, Zulia state
ArticleAbstract: Background: The accumulation of body fat has a genetic basis. Given the importance of UCP3 in the rePalabras claves:-55C/T variant, Anthropometric abnormalities, Metabolic abnormalities, obesity, Rs1800849, UCP3Autores:Arráiz N., Camacho M., Carem Prieto, Joselyn Zula, Levy A., Marcucci R., Marín E., Mújica A., Mujica E., Rojas-Quintero J., Urdaneta B., Valmore Bermúdez, Vivas M.Fuentes:googlescopusMutations in the coding region of dominium of union of apoliprotein B-100: Diagnosis of apoliprotein B familiar defect
ArticleAbstract: Hypercholesterolemia is a risk factor for cardiovascular disease. Alterations in the genes encodingPalabras claves:ApoB-100, Arg3480Pro mutation, Familial defective apolipoprotein B, hypercholesterolemiaAutores:Añez-Ramos R., Arráiz N., Bello L.M., Carem Prieto, Escalona C., González M.C., Joselyn Zula, Mújica A., Mujica E., Pacheco M., Roque W., Toledo A.C., Valmore BermúdezFuentes:googlescopusMelanocortin-4 receptor (MC4R) gene allelic variants and its impact on obese phenotype expression
ArticleAbstract: Obesity is a public health problem worldwide, due to its association with other morbidities such asPalabras claves:Allelic variants, body mass index, MC4R, Melanocortin receptor, obesityAutores:Amell A., Arráiz N., Camacho M., Carem Prieto, González M.C., Gonzalez R., Levy A., Marcucci R., Mujica E., Rojas-Quintero J., Sánchez M.P., Sofía M., Urdaneta B., Valmore BermúdezFuentes:scopusLipid profile reference intervals in individuals from Maracaibo, Venezuela: An insight from the Maracaibo City Metabolic Syndrome prevalence study
ArticleAbstract: Objectives: Cardiovascular diseases are the main cause of death in adults worldwide. Dyslipidemias aPalabras claves:Cardiovascular disease, dyslipidemia, lipid profile, Reference intervalsAutores:Aguirre M.A., Añez-Ramos R., Angulo V., Arráiz N., Bello L.M., Carem Prieto, Fortul Y., González M.C., Linares S., Marcano R.P., Naguib A., Pacheco E., Ponce C.C., Rojas-Quintero J., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Villalobos M.Fuentes:googlescopusLipoprotein (a): Molecular and Epidemiologic basis about its role in cardiovascular diseases
ReviewAbstract: In 1963, Kare Berg at the University of Oslo discovered Lp(a) as a new human plasmatic antigen set.Palabras claves:Apolipoprotein(a), Atherogenesis, Cardiovascular disease, lipoprotein(a), Lp (a), thrombogenesisAutores:Aparicio D., Arráiz N., Canelón R., Cano-Ponce C., Cizcek A., Faria J., Gotera D., Guerra-Torres X.E., Manuel V., Rojas E.R., Sorell L.T., Valmore BermúdezFuentes:scopusSerum levels of lipoprotein(a) and its behavior in the state of Zulia: 10 Years of research
ReviewAbstract: Lipoprotein Lp(a) is considered one of the most important independent risk factors for atherosclerotPalabras claves:Cardiovascular disease, Coronary artery disease, Hormone replacement therapy, lipoprotein(a), myocardial infarction, Physical activity, risk factorAutores:Amell A., Añez-Ramos R., Arias F.B., Arráiz N., Cabrera M., Cano-Ponce C., Cruz S., González M.C., Mejías J.C., Mengual-Moreno E., Nava A., Rojas-Quintero J., Silva C., Sorell G L., Souki-Rincón A., Toledo A.C., Torres W., Torres Y., Valmore BermúdezFuentes:scopusSerum lipoprotein (a) in patients post myocardial infarction
ArticleAbstract: Lipoprotein (a) [Lp (a)] is considered an independent risk factor for cardiovascular disease. In ourPalabras claves:Abdominal circumference, body mass index, dyslipidemia, Lipoprotein (a), myocardial infarctionAutores:Amell A., Añez-Ramos R., Arráiz N., Cano-Ponce C., Carem Prieto, Carrillo M., Cruz S., González M.C., Joselyn Zula, Montiel M., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Vergara P.M.Fuentes:googlescopus